SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101 (API ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Dren Bio entered into a strategic collaboration with Sanofi to develop therapies for autoimmune diseases in a deal worth up to $1.7 billion. Sobi plans to buy Arthrosi Therapeutics for $950 million ...

Alcami's new sterile fill-finish line supports vial formats from 2R to 30R, enhancing clinical and commercial manufacturing capabilities. Cambrex's $120 million investment will increase its Charles ...

Nuvation Bio (NUVB) has decided to halt the development of NUV-1511, the initial compound in its innovative drug-drug conjugate program. Although NUV-1511, under investigation for solid tumors, was ...

Drug developer stocks strengthened further through September and October, with the BioWorld Drug Developers Index (BDDI) rising from a 7.69% gain at the end of August, to 24.91% through the third ...

Recognition underscores CrossBridge Bio’s leadership in advancing next-generation dual-payload ADCs toward the clinic. CrossBridge Bio, a biopharmaceutical company pioneering next-generation ...

OKLAHOMA CITY, Oct. 29, 2025 /PRNewswire/ -- Wheeler Bio, a U.S.-based High Science/High Touch contract development and biomanufacturing organization (CDMO), today announced a strategic partnership ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

A rendering of the $5 billion manufacturing facility that Eli LIlly plans to build in Virginia's Goochland County near Richmond. The planned manufacturing plant will be the company's first-ever ...

The oPool + display platform combines technologies to make and test large numbers of antibodies at once. Antibodies are the critical targeting agents of the immune system and the crux of immune ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Fifteen years after he started ...